Sun Life Financial Reports 13% EPS Growth as Asia and U.S. Drive Q2 Strength
The Canadian insurer posted double-digit earnings growth driven by record results in Canada, accelerating momentum in Asia, and strong performance in U.S. health solutions.
Strong Quarter Across Business Lines
Sun Life Financial Inc. reported underlying earnings per share of $2.02 for the second quarter of 2026, representing 13% growth year-over-year and exceeding the company's medium-term target of 10% (earnings call, 2026-08-07). The Toronto-based insurer, with a market capitalization of approximately $45 billion, delivered underlying net income of $1.12 billion, while underlying return on equity reached 19.1%, approaching its 20% target.
"This was a strong quarter that reflected the strength of our premise, our disciplined execution, our business growth across key markets and the resilience of our diversified model," said Kevin Strain, President and Chief Executive Officer (earnings call, 2026-08-07).
Reported net income was $1.01 billion, compared with $716 million in the prior year period. The company maintained a strong capital position with a LICAT ratio of 145% and holding company cash of $2.3 billion.
Record Performance in Canada
Canada delivered record results with underlying net income of $427 million, up 23% from the prior year. Tim Deacon, Executive Vice President and Chief Financial Officer, attributed the performance to "favorable insurance experience" reflecting "sustainable benefits from the investments we've made over time in our people, processes and capabilities" (earnings call, 2026-08-07).
The Canadian wealth platform reached $286 billion in assets under management and administration, up 18% year-over-year, supported by record defined contribution sales.
Asia Momentum Accelerates
Asia showed broad-based strength with insurance sales increasing 20% to $875 million. Indonesia was a standout, with sales surging 69% due to the "ongoing success of our expanded CIMB partnership" (earnings call, 2026-08-07). Hong Kong sales grew 20%, supported by a 28% increase in advisers to nearly 4,000.
Strain emphasized that "the breadth of growth is coming from multiple markets in multichannel," which creates "a more resilient and higher-quality growth profile over time" (earnings call, 2026-08-07).
U.S. Business Gains Traction
U.S. operations reported underlying net income growth of 15%, driven by medical stop-loss, which saw sales jump 86% year-over-year. The growth reflected "disciplined pricing, strong underwriting and continued success in winning attractive business" (earnings call, 2026-08-07).
In dental, the company continued repositioning efforts to improve profitability through portfolio management and expense discipline, with actions contributing to improved loss ratios in the quarter.
Asset Management Integration
Sun Life Asset Management completed its first full quarter operating as a unified platform, with underlying net income of $252 million, up 4% year-over-year. The business demonstrated strong momentum with capital raising of $4.7 billion and deployment activity of $6.2 billion, up 8% and 42% respectively.
Notably, the Indian joint venture Sun Life Asset Management won a large fixed income mandate that doubled assets under management to $113 billion.
MFS continued to face industry headwinds with net outflows, though its active ETF platform showed traction with inflows more than tripling versus the prior year, reaching $3 billion in assets under management.
AI and Digital Transformation
The company announced its founding membership in an AI consortium with Scotiabank and TELUS to "build the infrastructure, governance and control needs to employ AI responsibly at scale in regulated industries" (earnings call, 2026-08-07). Sun Life deployed AI solutions across contact centers in Indonesia and launched tools to accelerate adviser onboarding in Asia.
MarginX data shows the company's next earnings report is scheduled for November 4, 2026, with an earnings call on November 5, 2026.
This article was generated by MarginX from the earnings call on 2026-08-07. It is not investment advice.